Radar › Companies › HealthTech · Manchester
Radar · HealthTech in Manchester

Best HealthTech Companies in Manchester, United Kingdom

The 81 best HealthTech companies in Manchester, United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Novalar Pharm.

81companies tracked
$140.7Mdisclosed funding
0unicorns
25have raised
FLIAR INTELLIGENCE · HEALTHTECH × MANCHESTER

Our analysis of 80 HealthTech companies

$5.5b in tracked funding; 96% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

80companies analysed
96%cloud-native stacks
2025funding peak (by rounds)
2unicorns
2018median founding year
77kcombined LinkedIn audience
48%of audience held by top 3
3companies hiring publicly (12 mo)

Ranked: Best HealthTech companies in Manchester

#CompanyDisclosed fundingLast roundEmployeesFounderTech stackStagePatents & IP focusRecent signals
1Novalar Pharm
Online pharmacy store
$53M191 mo ago—Robert Stefanovich
CFO
—Series D——
2C4X Discovery
Developer of optimized drug discovery and design services
$43M29 mo ago46—WordPressMySQLPHP+15Public130 patents
Small‑molecule inhibitors of MALT1, NRF2 agonists, and integrin blockers for immuno‑inflammatory therapy
—
3Prevayl
Provider of AI-based smart wearable clothing
$11M60 mo ago48Adam Crofts
Founder & CEO
—Seed127 patents
Wearable garments integrating sensors for health/activity monitoring and recovery scoring
—
4Biorelate
Developer of an artificial intelligence platform for biomedical literature curation and knowledge graph…
$9M42 mo ago23
23 → 36 (+57%)
Daniel Jamieson
Founder & CEO
WebflowMemberStackApple iCloud Mail+20Series A—2 job openings
5Now Healthcare
Telehealth solutions in UK
$5M108 mo ago34——Deadpooled——
6Recourse
AI-powered learning and assessment provider for healthcare
$4M40 mo ago6—WebflowApple iCloud MailGoogle Workspace+16Seed—1 award
7Manchester Imaging
Dental imaging software
$4M50 mo ago5Tony Travers
Chief Executive Officer
—Seed——
8Howz
Provider of smart solution for independent living for elderly
$3M112 mo ago9—Cart FunctionalitySquarespace CommerceSquarespace+23Seed——
9Flynotes
Provider of digital consent form solution for clinical practitioners
$3M69 mo ago6Govin Murugachandran
Founder & CEO
—Deadpooled——
10Xploro
AI-led platform offering health and disease prevention information
$2M40 mo ago5Dom Raban
Co-Founder & CEO
—Seed——
11Keia
Online paltform to find wellness providers
$2M54 mo ago4——Seed——
12Dr Fertility
Online store offering fertility and women health products
$1M84 mo ago10Lucy Buckley
Co-Founder
—Deadpooled——
13Pill Connect
Dosing system for pill dispensers
$658K16 mo ago5——Seed8 patents
Automated medication dispensing systems with modular pill sorting and delivery mechanisms.
—
14AQ-Trials
Provider of a clinical trial management system designed for researchers
$304K41 mo ago6Ash Mahmud
Co-Founder
—Seed—1 launch
15MedCircuit
AI-based software solution for collecting medical information from patients
$224K97 mo ago1Lanre Olaitan
Co-Founder
—Deadpooled——
16Recoverlution
Provider of community and wellness platform for recovering addicts
$172K38 mo ago9——Seed——
17Clin-E-Cal
App offering interactive children game for inhaler training
$171K68 mo ago2Elizabeth Crawford
CEO & MD
—Seed——
18Spotlight Pathology
Developer of AI-powered decision support tools for blood cancer diagnosis
37AI top 35%Talent top 38%Funding bottom 47%Growth bottom 42%
All 7 signals ▾
AItop 35%
Talenttop 38%
Fundingbottom 47%
Growthbottom 42%
Marketbottom 37%
Globalbottom 29%
Newsbottom 21%
AI: Product described with: ai-powered, machine learning
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
rank vs industry peers · Fliar Intelligence Index 37/100
$162K3 mo ago—Richard Byers
Co-Founder
—Seed——

Top 12 HealthTech companies in Manchester

#1
Seed · Manchester, England · founded 2020
$162Kraised
▾

Developer of AI-powered decision support tools for blood cancer diagnosis. It offers machine learning technology that integrates with existing digital pathology infrastructure to improve pathology services. The AI software helps to minimize turnaround times, reduce pathologists’ hands-on time, and improve the objectivity of assessments. The technology detects cancer, differentiates cell types, performs automated cell counts and spatial analyses, quantifies heterogeneity, and discovers novel molecular biomarkers for patient risk stratification. It combines insights from multi-modal datasets.

Fliar Intelligence Index™ 37how this company ranks against its industry peers
AI
top 35%
Talent
top 38%
Funding
bottom 47%
Growth
bottom 42%
Market
bottom 37%
Global
bottom 29%
AI: Product described with: ai-powered, machine learning
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Funding: Raised $162k across 3 rounds · 3 rounds over 2 yrs (1.5/yr) · Last round Seed (Mar 2026)
Audience (LinkedIn): 686 LinkedIn followers
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: AI Scientist, Implementation Manager
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
  • Mar 2026Seed$1.9M
  • Apr 2025Seed$483.9K
  • Jul 2024Seed$162K
Founders & team
Richard ByersCo-FounderMartin FergieCo-Founder & CTO
Investors
LYVA Labs, Deepbridge Capital, EHE Ventures, UK Innovation Science & Seed Fund, River Capital, Lcrseedfund
#2
Public · Manchester, England · founded 2008 · 46 employees
$43.2Mraised
▾

Developer of optimized drug discovery and design services. The company has two proprietary and synergistic software platforms Taxonomy3, a human genetics analysis platform, and Conformetrix, which determines the 3D shape of drug molecules. The company's NMR technology provides templates for drug discovery and design and information for drug candidate optimization. The company's pipeline has candidates for the treatment of addiction (Oral Orexin-1 Antagonist), diabetes (oral GPR142 and GLP-1 agonists), inflammation, and oncology.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers — 7.1% of this cohort's audience
Activity: 1 awards announced in 12 mo
Funding rounds
  • Jan 2024Post IPO$11M
  • Aug 2022Post IPO$6.9M
  • Oct 2020Post IPO$914.9K
  • Oct 2019Post IPO—
Investors
Aquarius Equity Partners, AstraZeneca, Gov, Panmure Gordon, Adams, Calculus Capital
Tech stack
Amazon S3Amazon Web ServicesComplianzContact Form 7GodaddyGoogle Analytics
#3
Seed · Manchester, England · founded 2013 · 5 employees
$658.4Kraised
▾

Dosing system for pill dispensers. The dosing system allows patients to monitor medication adherence through the app. The dose schedules can be programmed and attached to the bottles to monitor adherence. The features include automated dispensing, real-time data capture, remote monitoring, and reusable attachment with the bottles.

Funding rounds
  • Feb 2025Seed—
  • Nov 2020Seed$658.4K
Investors
Catapult Ventures, Shallcross Partners, Praetura Ventures, The GM&C Life Sciences Fund, Profeta, Kin Capital
#4
Series D · Manchester, England · founded 2000
$53.2Mraised
▾

Novalar Pharm is an online pharmacy store. Offers medicines across a range of disease categories including allergies, anti-infectives, diabetes, women's health, weight loss, cardiovascular diseases among others.

Funding rounds
  • Jul 2010Series D$1M
  • Nov 2007Series D$30M
  • Jan 2006Series C$13M
  • 2004Series B$5.1M
Founders & team
Robert StefanovichCFO
Investors
New Enterprise Associates, Domain Associates, SR One, Montreux Equity Partners, Endeavour Vision
#5
Series A · Manchester, England · founded 2014 · 23 employees
$8.7Mraised
▾

Developer of an artificial intelligence platform for biomedical literature curation and knowledge graph construction. This technology identifies and extracts cause-and-effect relationships from scientific literature to support drug discovery and biological research. The platform enables the analysis of connections between genes, diseases, and chemical entities to assist in target identification, biomarker selection, and indication expansion. By automating the processing of biomedical data, the system provides evidence-based insights for researchers and scientists.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 8.1% of this cohort's audience
Hiring: 2 hiring posts in 12 mo (public) · momentum +2 · hiring: hyper growth business, Senior Solutions Consultant
Funding rounds
  • Nov 2022Series A$7.8M
  • Feb 2019Grant (prize money)—
  • Sep 2018Seed$914.6K
  • Mar 2016Seed—
Founders & team
Daniel JamiesonFounder & CEO
Investors
Innovate UK, Catapult Ventures, YFM Equity Partners, Maven Capital Partners, Northern Powerhouse Investment Fund, Triple Point
Tech stack
AhrefsAnime.JsApple Icloud MailCdnjsCloudflareCloudflare Bot Management
#6
Seed · Manchester, England · founded 2018 · 6 employees
$4.3Mraised
▾

AI-powered learning and assessment provider for healthcare

LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers — 6.0% of this cohort's audience
Activity: 1 awards announced in 12 mo
Funding rounds
  • Feb 2023Grant (prize money)$1.2M
  • Dec 2022Seed$4.3M
Investors
SBRI Healthcare, Par Equity, Northern Gritstone, Praetura Ventures, Gmc Life Sciences, Kin Capital
Tech stack
Apple Icloud MailCdnjsCloudflareFancyboxGoogle AnalyticsGoogle Font Api
#7
Seed · Manchester, England · founded 2019 · 48 employees
$10.6Mraised
▾

Prevayl provides AI-based smart wearable clothing. The smart clothing provided by the company tracks the body’s biodata and provides custom insight solutions underpinned by biometric data. The wearable continuously tracks health& performance and measures biodata, through AI and machine learning.

Funding rounds
  • Jun 2021Seed$10.6M
Founders & team
Adam CroftsFounder & CEO
Investors
Stonebridge, Hambleden Capital
#8
Seed · Manchester, England · founded 2014 · 5 employees
$4Mraised
▾

Manchester Imaging, a spin-out from the University of Manchester, develops imaging software for dental health. Its proprietary technology uses statistically-based image analysis for sensitive modeling and classification of dental features. It's lead product CariesDent detects the presence of caries in tooth enamel before it is visible using manual inspection.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 328 LinkedIn followers
Funding rounds
  • Apr 2022Seed$722.3K
  • Mar 2021Seed$589.4K
  • Apr 2020Seed$237.8K
  • Feb 2019Seed$72.2K
Founders & team
Tony TraversChief Executive Officer
Investors
The GM&C Life Sciences Fund, Northern Powerhouse Investment Fund, Co Angel Investment, Greater Manchester Combined Authority, Mercia, Catapult Ventures
Tech stack
WordpressMysqlPhpNginx
#9
Seed · Manchester, England · founded 2019 · 5 employees
$1.7Mraised
▾

AI-led platform offering health and disease prevention information. The platform uses augmented reality, artificial intelligence and gameplay technologies to provide health-related information. Children can interact with the avatar chatbot, view 3D augmented reality interactive models of hospital environments, and processes, play treatment-themed games, maintain health diary. It also offers a parent app to manage appointments and a clinician management system.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 7.5% of this cohort's audience
Funding rounds
  • Jan 2023Seed$1.7M
  • Nov 2021Conventional Debt$134.2K
Founders & team
Dom RabanCo-Founder & CEODaniel TaylorCo-Founder
Investors
University Hospitals, Jumpstart Ventures, Comeback Capital, Right Side Capital Management, The Greater Manchester Export Fund, VentureOut
#10
Seed · Manchester, England · founded 2015 · 4 employees
$1.5Mraised
▾

Keia is an online platform enabling the user to find wellness providers. The user can search for the type of wellness provider at the location of preference. The user can compare prices and details to book a wellness provider or class.

Funding rounds
  • Dec 2021Seed$406K
  • Mar 2021Seed$203.2K
  • Apr 2020Seed$215K
  • Mar 2019Seed$128.4K
Investors
Deepbridge Capital
Tech stack
TypescriptNode.JsBootstrapAngularExpressVonage Video Api
#11
Deadpooled · Manchester, England · founded 2014 · 34 employees
$5.1Mraised
▾

Now Healthcare is a telehealth company in the UK. Operates Dr.Now - a platform for cloud-based medical consultations focused primarily on primary care. Users can seek consultation for diagnosis and seek prescriptions from the GPs using the app. Dr.Now service is offered on a subscription basis. Prescriptions are then delivered to the home by Now Pharmacy - The company's drugs distribution unit.

Funding rounds
  • Jun 2017Series A$5.1M
Investors
Medicash
#12
Deadpooled · Manchester, England · founded 2017 · 6 employees
$2.6Mraised
▾

Provider of digital consent form solution for clinical practitioners. The company offers personalized consent forms according to the need of the practitioners. The solution is integrated with health records of patients for access.

Funding rounds
  • Sep 2020Seed$1.9M
  • Jan 2018Seed$767.5K
Founders & team
Govin MurugachandranFounder & CEO
Investors
Northern Powerhouse Investment Fund, Maven Capital Partners, The GM&C Life Sciences Fund, PUBLIC, Catapult Ventures

Funding & investor landscape

$140.7Mtotal disclosed funding
20companies funded
51disclosed rounds
0rounds last 90 days
Most active investors
Northern Powerhouse Investment Fund6 rounds
The GM&C Life Sciences Fund5 rounds
Catapult Ventures4 rounds
Praetura Ventures3 rounds
Deepbridge Capital2 rounds
Greater Manchester Combined Authority2 rounds
Innovate UK2 rounds
Kin Capital2 rounds
Maven Capital Partners2 rounds
Mercia2 rounds

Notable founders

Richard Byers
Co-Founder · Spotlight Pathology
Martin Fergie
Co-Founder & CTO · Spotlight Pathology
Robert Stefanovich
CFO · Novalar Pharm
Daniel Jamieson
Founder & CEO · Biorelate
Adam Crofts
Founder & CEO · Prevayl
Tony Travers
Chief Executive Officer · Manchester Imaging
Dom Raban
Co-Founder & CEO · Xploro
Daniel Taylor
Co-Founder · Xploro
Govin Murugachandran
Founder & CEO · Flynotes
Ash Mahmud
Co-Founder · AQ-Trials
Lucy Buckley
Co-Founder · Dr Fertility
Elizabeth Crawford
CEO & MD · Clin-E-Cal
Prism market signals · United Kingdom · country-scoped Prism corpus, 667,211 docs

Market landscape — 10 sub-themes by coverage

Share of HealthTech coverage by sub-theme.

Regulatory-risk over time flat

Funding & growth over time

funding rising · growth rising

RESEARCH IN MANCHESTER · Health & Bio

How research on Digital Health in Manchester is moving

A read on the academic research around Digital Health in Manchester — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 260 papers.

260 papers · stance +0.08 · 9% breakthrough · 60% concern
breakthrough · advancement · concern
top institutions
  • University of Manchester175
  • Manchester Academic Health Science Centre122
  • Greater Manchester Mental Health NHS Foundation Trust38
  • NIHR Manchester Biomedical Research Centre24
  • Manchester University NHS Foundation Trust23
leading researchers
Sandra Bucci · Rhiannon E Hawkes · Dawn Dowding · Emma Stanmore · David French · Lisa M Miles
prism intelligence · tone & topics
86% positive · 11% critical tone
HealthcareMental HealthPublic HealthPolicyGovernmentSociety
▲ Breakthroughs21 · 8%
▲ 4%→8% share
▲2.0× share momentum0 median citations86% since 2021mostly methods-led
Breakthroughs are rising (4%→8% of field), led by Health informatics.
rising sub-themes (early→recent)
  • Health informatics2→4
  • Nursing research2→3
Newly emergingHealth care 0→5 · Wearable computer 0→4 · Wearable technology 0→3
Landmark Actissist: Proof-of-Concept Trial of a Theory-Driven Digital Intervention for Psychosis · 224 cites
◆ Advancements72 · 28%
▲ 23%→28% share
▲1.2× share momentum1 median citations86% since 2021mostly empirical
Advancements are rising (23%→28% of field), led by Intervention (counseling).
rising sub-themes (early→recent)
  • Intervention (counseling)1→16
  • Psychological intervention1→16
  • Health care3→16
  • Mental health1→11
  • Health informatics3→8
Newly emergingChronic pain 0→8 · Chronic disease 0→8 · Activities of daily living 0→8
Landmark The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual re · 1,025 cites
▼ Concerns137 · 53%
▼ 65%→51% share
▼0.8× share momentum4 median citations82% since 2021mostly empirical
Concerns are cooling (65%→51% of field), led by Health care.
rising sub-themes (early→recent)
  • Health care6→34
  • Mental health2→24
  • Public health1→23
  • Psychological intervention2→23
  • Health informatics9→27
Newly emergingKey (lock) 0→8 · Telemedicine 0→7 · Pandemic 0→5
Landmark The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview · 1,479 cites

Common questions

How many HealthTech companies are there in Manchester, United Kingdom?
Radar tracks 81 indexable HealthTech companies headquartered in Manchester, United Kingdom that meet our profile-completeness bar.
What is the total funding raised by HealthTech companies in Manchester, United Kingdom?
The HealthTech companies in Manchester, United Kingdom on this list have raised a combined $140.7M in disclosed equity funding across 20 funded companies.
Which is the highest-funded HealthTech company in Manchester, United Kingdom?
Novalar Pharm is the highest-funded HealthTech company in Manchester, United Kingdom, with $53.2M in disclosed equity funding.
How many HealthTech companies in Manchester, United Kingdom are funded?
20 of the 81 HealthTech companies in Manchester, United Kingdom on this list have disclosed at least one equity funding round.
How many HealthTech unicorns are there in Manchester, United Kingdom?
None of the HealthTech companies in Manchester, United Kingdom on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Manchester, United Kingdom HealthTech companies?
The most active investors in Manchester, United Kingdom HealthTech companies on this list include Northern Powerhouse Investment Fund, The GM&C Life Sciences Fund, Catapult Ventures, Praetura Ventures, Deepbridge Capital.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon